Table 4

Estimated number of users per 10 000 population with a chronic presentation of an NCD

CountryAdults with hypertensionAdults with diabetesChildren with diabetesAdults with coronary diseaseAdults with cerebrovascular diseaseAdults with heart failureAdults with asthmaChildren with asthmaPeople with asthmaAdults with COPD
Bangladesh954610261454716351290641269
Central African Republic1398410182421710391373764205
Egypt1021456192072231463294757295
Guinea136144519188147373392765207
Indonesia1268451191484016481274755310
Iraq856673292072531390374764201
Jordan7031062452072931439319758226
Lebanon1609883372073931538212750380
Liberia120244919188147370395765197
Philippines830391171485116543324867260
Sierra Leone164849921188137379385764191
Syrian Arab Republic990752322073031428332760229
Turkey944689292072631505247752339
Ukraine3484843362856842389140529513
  • Chronic NCD presentations include management of stable coronary disease, heart failure, hypertension, diabetes, COPD or asthma.

  • COPD, chronic obstructive pulmonary disease; NCD, non-communicable disease.